Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Steba Biotech S.A.
Sponsor

Steba Biotech S.A.

Luxembourg 14a Rue Des Bains, 1212 Luxembourg, Luxembourg

About the sponsor

Steba Biotech S.A. focuses its clinical research on low-grade upper tract urothelial cancer, with particular attention to tumors arising in the renal pelvis, calyces, and ureter. The sponsor’s trial activity centers on evaluating treatment approaches for disease control within the upper urinary tract.

  • Upper tract urothelial carcinoma
  • Renal pelvis tumors
  • Ureteral malignancy

The clinical program reflects interest in organ-preserving management of localized urothelial disease in the upper urinary tract.

About Specializations

Steba Biotech S.A. runs clinical trials in conditions such as Transitional cell cancer of the renal pelvis and ureter, Ureteric cancer, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Transitional cell cancer of the renal pelvis and ureter+1

Not recruiting
Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Padeliporfin
  • Sponsor:Steba Biotech S.A.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.